Anzahl der Publikationen: 3
Zeitschriftenartikel
Landewé, Robert B. M. ORCID: https://orcid.org/0000-0002-0577-6620; Kroon, Féline P. B. ORCID: https://orcid.org/0000-0002-8940-0582; Alunno, Alessia ORCID: https://orcid.org/0000-0003-1105-5640; Najm, Aurélie ORCID: https://orcid.org/0000-0002-6008-503X; Bijlsma, Johannes W. J. ORCID: https://orcid.org/0000-0002-0128-8451; Burmester, Gerd-Rüdiger R. ORCID: https://orcid.org/0000-0001-7518-1131; Caporali, Roberto; Combe, Bernard; Conway, Richard ORCID: https://orcid.org/0000-0003-2538-3362; Curtis, Jeffrey R.; Elkayam, Ori; Gossec, Laure ORCID: https://orcid.org/0000-0002-4528-310X; Heijstek, Marloes W.; Haupt, Lukas; Iagnocco, Annamaria ORCID: https://orcid.org/0000-0001-5592-724X; Isaacs, John D. ORCID: https://orcid.org/0000-0002-6103-7056; Juhász, István Ábel; Makri, Suzi; Mariette, Xavier ORCID: https://orcid.org/0000-0002-4244-5417; McInnes, Iain B.; Mehta, Puja ORCID: https://orcid.org/0000-0001-9459-9306; Mueller-Ladner, Ulf; Schulze-Koops, Hendrik ORCID: https://orcid.org/0000-0002-1681-491X; Smolen, Josef S.; Wiek, Dieter; Winthrop, Kevin L. ORCID: https://orcid.org/0000-0002-3892-6947; Navarro-Compán, Victoria ORCID: https://orcid.org/0000-0002-4527-852X und Machado, Pedro M. ORCID: https://orcid.org/0000-0002-8411-7972
(2022):
EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update.
In: Annals of the Rheumatic Diseases, Bd. 81, Nr. 12: S. 1628-1639
Aletaha, Daniel ORCID: https://orcid.org/0000-0003-2108-0030; Kerschbaumer, Andreas ORCID: https://orcid.org/0000-0002-6685-8873; Kastrati, Kastriot; Dejaco, Christian ORCID: https://orcid.org/0000-0002-0173-0668; Dougados, Maxime ORCID: https://orcid.org/0000-0003-3009-6229; McInnes, Iain B.; Sattar, Naveed; Stamm, Tanja A. ORCID: https://orcid.org/0000-0003-3073-7284; Takeuchi, Tsutomu ORCID: https://orcid.org/0000-0003-1111-8218; Trauner, Michael; van der Heijde, Désirée ORCID: https://orcid.org/0000-0002-5781-158X; Voshaar, Marieke; Winthrop, Kevin L. ORCID: https://orcid.org/0000-0002-3892-6947; Ravelli, Angelo ORCID: https://orcid.org/0000-0001-9658-0385; Betteridge, Neil; Burmester, Gerd-Rüdiger R. ORCID: https://orcid.org/0000-0001-7518-1131; Bijlsma, Johannes W. J. ORCID: https://orcid.org/0000-0002-0128-8451; Bykerk, Vivian; Caporali, Roberto; Choy, Ernest H. ORCID: https://orcid.org/0000-0003-4459-8609; Codreanu, Catalin; Combe, Bernard; Crow, Mary K. ORCID: https://orcid.org/0000-0002-7881-2020; Wit, Maarten de ORCID: https://orcid.org/0000-0002-8428-6354; Emery, Paul ORCID: https://orcid.org/0000-0002-7429-8482; Fleischmann, Roy M. ORCID: https://orcid.org/0000-0002-6630-1477; Gabay, Cem; Hetland, Merete Lund; Hyrich, Kimme L. ORCID: https://orcid.org/0000-0001-8242-9262; Iagnocco, Annamaria ORCID: https://orcid.org/0000-0001-5592-724X; Isaacs, John D. ORCID: https://orcid.org/0000-0002-6103-7056; Kremer, Joel M.; Mariette, Xavier ORCID: https://orcid.org/0000-0002-4244-5417; Merkel, Peter A. ORCID: https://orcid.org/0000-0001-9284-7345; Mysler, Eduardo F.; Nash, Peter ORCID: https://orcid.org/0000-0002-2571-788X; Nurmohamed, Michael T. ORCID: https://orcid.org/0000-0002-6274-1934; Pavelka, Karel; Poor, Gyula; Rubbert-Roth, Andrea ORCID: https://orcid.org/0000-0002-9016-2833; Schulze-Koops, Hendrik ORCID: https://orcid.org/0000-0002-1681-491X; Strangfeld, Anja ORCID: https://orcid.org/0000-0002-6233-022X; Tanaka, Yoshiya ORCID: https://orcid.org/0000-0002-0807-7139 und Smolen, Josef S.
(2022):
Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.
In: Annals of the Rheumatic Diseases, Bd. 82, Nr. 6: S. 773-787
Smolen, Josef S.; Mease, Philip; Tahir, Hasan; Schulze-Koops, Hendrik; de la Torre, Inmaculada; Li, Lingnan; Hojnik, Maja; Sapin, Christophe; Okada, Masato; Caporali, Roberto; Gratacos, Jordi; Goupille, Philippe; Liu Leage, Soyi; Pillai, Sreekumar und Nash, Peter
(2020):
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naive to biological disease-modifying antirheumatic drug: final results by week 52.
In: Annals of the Rheumatic Diseases, Bd. 79, Nr. 10: S. 1310-1319
[PDF, 2MB]
Diese Liste wurde am
Sat Dec 21 20:06:02 2024 CET
erstellt.